Dalmia Cement (Bharat) Ltd (DCBL) has agreed to sell its entire investment of 18,723,743 equity shares in Dalmia Bharat Refractories Ltd to M/s Sarvapriya Healthcare Solutions Private Ltd. The transaction represents 42.36 per cent of share capital, at a total consideration of INR8000m (US$97.12m), and forms part of DCBL’s strategy to exit non-core business/investment, according to the company.
Crown Cement earned a profit after tax of BDT1001m in FY24
Crown Cement PLC, in Bangladesh, recently released its annual report for FY23-24. During the las...